Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-014860

Director acquired 24,720 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mulroy Michael H. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-06-18 Exercise or conversion : show line 1 in the form +24,720 $2.20 $54,384 251,555 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-18 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −24,720 0 D
Loading xslF345X03/ownership.xml…